IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.2847
-0.0003 (-0.11%)
Apr 1, 2025, 4:00 PM EST - Market closed
IGC Pharma Employees
IGC Pharma had 67 employees as of March 31, 2024. The number of employees increased by 6 or 9.84% compared to the previous year.
Employees
67
Change (1Y)
6
Growth (1Y)
9.84%
Revenue / Employee
$18,448
Profits / Employee
-$131,478
Market Cap
22.69M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IGC News
- 7 hours ago - IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health - Accesswire
- 6 days ago - IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep Disturbances - Accesswire
- 12 days ago - IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences - Accesswire
- 15 days ago - IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in Florida - Accesswire
- 20 days ago - IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock. - Accesswire
- 22 days ago - IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP) about the "Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results" - Accesswire
- 4 weeks ago - IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer's and Dementia Detection - Accesswire
- 5 weeks ago - IGC Pharma Expands Holiby(TM) Product Line With 'Longevity' and 'Renew' - Targeting the Multi-Billion-Dollar Anti-Aging Market - Accesswire